Employing a variety of methodologies, including Mendelian randomization, gene-drug interaction analyses, and retrospective cross-sectional studies, our investigation reveals that circulating KRT19 could potentially induce BMI-adjusted PCOS via mechanisms involving GNS and testosterone. The gene discussed is KRT19; the disease is polycystic ovary syndrome.